Issue of Equity
Updated : 16:38
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
5 February 2020
Scotgold Resources Limited
("Scotgold" or the "Company")
Issue of Equity
Scotgold Resources Limited (AIM: SGZ) announces that 2,856 fully paid ordinary Scotgold shares ("Option Shares") have been issued on conversion of options exercisable at £0.40 on or before 31 December 2019. Notices of exercise for these options were received prior to expiry on 31 December 2019, however issue was delayed whilst further information was sought from the option holders to enable issue.
Application for Admission
Application will be made for the 2,856 Option Shares to be admitted to trading on AIM ("Admission") and Admission is expected to take place on or around 11 February 2020.
Total Voting Rights
Following Admission, the Company's enlarged issued share capital will comprise 51,351,733 ordinary shares with voting rights. The Company does not hold any shares in treasury, therefore the total number of shares in the Company with voting rights will be 51,351,733. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.
For further information please contact:
Scotgold Resources Limited Richard Gray | Tel: +44 (0)1838 400 306 |
SP Angel Corporate Finance LLP Nomad and Broker Ewan Leggat / Charlie Bouverat | Tel: +44 (0)20 3470 0470 |
Capital Markets Consultants Financial PR Simon Rothschild | Tel: +44 (0) 7703 167 065 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.